Use of digital tools for clinical trials triples during pandemic; surveyA new poll of clinical trial sponsors has found that around nine out of 10 of them are Share XUse of digital tools for clinical trials triples during pandemic; surveyhttps://pharmaphorum.com/news/use-of-digital-tools-for-clinical-trials-triples-during-pandemic-survey/
Data dive finds cheap diuretic could be Alzheimer’s drugA data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have Share XData dive finds cheap diuretic could be Alzheimer’s drughttps://pharmaphorum.com/news/data-dive-finds-cheap-diuretic-could-be-alzheimers-drug/
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcastEpisode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply Share XNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-amit-nastik-pharma-supply-chain/
WHO cautions against overestimating AI’s impact on healthArtificial intelligence (AI) has the potential to improve the delivery of healthcare, but only if ethics and human Share XWHO cautions against overestimating AI’s impact on healthhttps://pharmaphorum.com/news/who-cautions-against-overestimating-ais-impact-on-health/
Key insights for a successful first-time product launchPre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of Share XKey insights for a successful first-time product launchhttps://pharmaphorum.com/sales-marketing/key-insights-for-a-successful-first-time-product-launch/
COVID heralds a faster future for drug development (if stakeholders can collaborate)COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right Share XCOVID heralds a faster future for drug development (if stakeholders can collaborate)https://pharmaphorum.com/views-and-analysis/covid-heralds-a-faster-future-for-drug-development-if-stakeholders-can-work-together/
Solving the “information challenge” of rare disease diagnosisGetting a diagnosis is often the biggest challenge facing a rare disease patient in the UK. We take Share XSolving the “information challenge” of rare disease diagnosishttps://deep-dive.pharmaphorum.com/magazine/research-and-development-2021/solving-the-information-challenge-of-rare-disease-diagnosis/
Life sciences must become cloud-first to seize the science of tomorrowIf the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed Share XLife sciences must become cloud-first to seize the science of tomorrowhttps://pharmaphorum.com/views-analysis-digital/life-sciences-must-become-cloud-first-to-seize-the-science-of-tomorrow/
Real-world evidence: breaking boundaries in rare diseaseThe COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have Share XReal-world evidence: breaking boundaries in rare diseasehttps://pharmaphorum.com/partner-content/real-world-evidence-breaking-boundaries-in-rare-disease/
